Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders

Xu, T., Yang, Y., Ward, R., Gao, L. and Liu, Y. (2013) Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders. Cellular Signalling, 25(12), pp. 2413-2423. (doi: 10.1016/j.cellsig.2013.07.025)

Full text not currently available from Enlighten.

Abstract

The orexin peptides (orexin A, orexin B) and their receptors (orexin receptor type 1, orexin receptor type 2) are involved in multiple physiological processes such as the regulation of sleep/wakefulness state, energy homeostasis and reward seeking. A result of this has been the development of small-molecule orexin receptor antagonists as novel therapies for the treatment of insomnia and drug addiction. Increased levels of signaling via the orexin peptide/receptor system may protect against obesity, while somewhat unexpectedly, orexins acting at orexin receptors induce dramatic apoptosis resulting in the significant reduction of cell growth in various cancer cell lines. Meanwhile, the orexin peptide/receptor system is also involved in cardiovascular modulation, neuroendocrine and reproduction regulation. This review summarizes the latest developments in deciphering the biology of orexin signaling as well as efforts to manipulate orexin signaling pharmacologically.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Ward, Dr Richard
Authors: Xu, T., Yang, Y., Ward, R., Gao, L., and Liu, Y.
College/School:College of Medical Veterinary and Life Sciences > School of Molecular Biosciences
Journal Name:Cellular Signalling
ISSN:0898-6568
ISSN (Online):1873-3913

University Staff: Request a correction | Enlighten Editors: Update this record